According to Eliseo’s report [51] based on supervised support vector machine learning, the high expression of TIGD1, to a certain extent, affects the sensitivity of tumour cells to cisplatin and improves patient outcomes after chemotherapy. This evidence concerns the gene TIGD1 and neoplasm.